Eco Animal Health - ECOVAXXIN® MS EU authorisation paves way for commercial launch

134 Views10 Nov 2025 23:00

Issuer-paid

SUMMARY

Eco Animal Health reports that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has adopted a Positive Opinion recommending the granting of EU marketing authorisation for ECOVAXXIN® MS, the EAH vaccine against Mycoplasma synoviae in poultry.
The authorisation represents a significant step towards commercialisation.
CEO David Hallas commented: "We are delighted to have received a Positive Opinion from the CVMP for ECOVAXXIN MS …This marks an exciting time for the Company, with further submissions expected over the next 12 months for additional products from our R&D pipeline, underpinning ECO's next phase of growth." Eco Animal Health expects the EMA to issue a marketing authorisation during the first quarter of 2026, so that the Group anticipates making ECOVAXXIN® MS commercially available in the European Union in the second half of 2026 (as expected and outlined in FY25 results).

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream